Contributing Member of the Healthcare Councils
Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
GLG News by this Author
GLG News is now G+ Insights
-
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
-
Technology is all too often the CAUSE of increased health care spending
March 3, 2008
As Healthcare Spending is Predicted to Exceed 4 Trillion in Less Than 10 Years, Technology will be Called upon to Stem the Tide | biz.yahoo.com
New technology is one factor in the ever-increasing cost of healthcare. New medical technologies are seldom cost-saving.
-
Gardasil for males--helping to fill in the gaps
March 3, 2008
Vaccinating Boys for Girls’ Sake? | www.nytimes.com
While the disease incidence (cervical carcinoma) is lower than many other cancers, thanks in part to successful screening, many of the remaining cases could be prevented by vaccinating EVERY female prior to the onset of sexual activity. Since this universal coverage is not likely, vaccinating males as well can help reduce the risk to those women who, for whatever reason, remain unvaccinated.
-
March 3, 2008
Google to store patients' health records | news.yahoo.com
Eventually, although not likely in the next ten years, electronic medical records (EMRs) will be the norm; once the interoperability issues are addressed, these records will be sharable across various networks. Until that time, systems such as Google's might serve some purpose.
-
Attempting to address a major drawback of current treatments
February 21, 2008
Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia | pharmalive.com
The alpha adrfenergic side effects of current treatments for BPH are significantly limiting in the use of these drugs.
-
Focusing on the delivery system, not the drug
February 21, 2008
Phosphagenics Initiates US Clinical Trials For Its Topical Retinoic Acid | www.pipelinereview.com
Novel delivery systems will generally be the next wave, whether for topical medications such as retinoic acid or systemic compounds, where the delivery system can target specific receptors or organs.
-
Again, too simplistic an approach
February 15, 2008
Memphis Chosen by HHS as One Community to Help Create "Travelocity of Health Care" | www.memphis.bizjournals.com
Rating physicians is not like rating hotels, airlines or restaurants. Unfortunately, the comments of lay people can only go so far in assessing a physician's performance.
-
Intriguing, but much more info needed
February 7, 2008
AIM Therapeutics Advances Asthma Therapeutics Program | www.pipelinereview.com
It would be great to be able to treat asthma and get steroid-like efficacy without the side effects. But there is not much to say without additional details.
-
Preventive care again...just not a popular item in US Healthcare policy
February 7, 2008
CDC: Too few adults get their vaccines | news.yahoo.com
Vaccines have been shown again and again to be cost-effective tools. Fortunately, pediatric vaccines are generally given, since the schools enforce the requirements. But adults would benefit as well.
-
February 7, 2008
FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11 | www.pipelinereview.com
Dry powder inhalers are easier for many young children to use than metered dose inhalers. This approval makes it possible to use a popular drug in younger patients who might not be able to use the MDI format.
-
Only very long-term studies will tell
February 4, 2008
Great Drug, but Does It Prolong Life? | www.nytimes.com
As is so often the case, the long-term benefits or risks of a particular therapy can only be evaluated by equally long-term studies. And the marketing and patent facts of life mean that drugs are released and pushed before all the data (or even sufficient data) is in, often with disastrous effects.
-
A big positive for kids, and a plus for Amegn and Wyeth
February 4, 2008
New Study Reports Enbrel (Etanercept) Significantly Improved Moderate to Severe Plaque Psoriasis in Children and Adolescents | www.wyeth.com
Pediatric psoriasis has always been difficult to treat without toxicity. Enbrel appears to have both efficacy and safety in this condition.
-
January 25, 2008
New therapy for old woes, Blue Cross measure aims to slow runaway costs, improve quality of healthcare | www.boston.com
Just a new name for capitation. Blue Cross will fix their costs in advance and insure themselves a profit; any losses will be borne by the already stressed providers.
-
What about continuity of care?
January 25, 2008
Upbeat diagnosis for clinics, Specialists in other states reject qualms about CVS units | www.boston.com
Who do you think the patient will call at 2 am when having a reaction to the prescribed medication? The CVS? Not likely.
-
Quicker diagnosis will shorten hospital stays and reduce costs--but prevention is key
January 17, 2008
MRSA | biz.yahoo.com
Yet another case of trying to close the barn door after the horse is out--the classic scenario of disease-focused American medical care. We can somewhat reduce costs by starting appropriate treatment earlier, but the majority of costs come from the initial care, need for re-operation, expensive antibiotics and prolonged intravenous care.
-
It is time to cover ALL Americans, equally
January 17, 2008
The New Insurance Frontier | www.healthleadersmedia.com
Many--not by any means all--uninsured have amde a decision that the costs of insurance, for them, outweigh the benefits. And, while they remain healthy, they may be right.
-
January 14, 2008
Universal flu vaccine shows early promise | www.fiercebioresearcher.com
Targeting a part of the influenza virus which does not mutate or a regular basis is a great idea. If the clinical data supports its efficacy, it would, indeed, be a novel approach to influenza vaccination.
-
Increased regulation will be the norm
January 14, 2008
Massachusetts opens door--a little--to retail clinic expansion | www.fiercehealthcare.com
Just as dissatisfaction with procedures in physicians' offices and hospitals has led to increased regulation (OSHA, CLIA, etc.), so will the inevitable problems which will show up in retail clinics lead to more cumbersome regulation.
-
Certainly should help sales volume!
January 14, 2008
Cialis Is Cleared for Daily Use | online.wsj.com
A new advertising motto--"Always ready!"
-
Another dumb governmental idea
January 14, 2008
DC passes pharma rep licensing bill | www.fiercepharma.com
This is not likely to have any significant effect. Chances are that licensing will be pretty much pro-forma (unless they decide to require a certain amount of scientific schooling and background) so licensing will just be another layer of governmental interference.
-
January 8, 2008
Ouch! Cervical cancer shots painful | news.yahoo.com
Ever had a sore arm for two days following a tetanus vaccine?
- Subscribe to Updates
-
This author consults with leading institutions through GLG
Most Popular Healthcare News
-
February 7, 2012
-
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
-
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
-
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
-
Medtech M&A activity accelerates in 2011
November 30, 2011
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.